Literature DB >> 2657420

Leupeptin alters the proteolytic processing of P126, the major parasitophorous vacuole antigen of Plasmodium falciparum.

A Debrabant1, P Delplace.   

Abstract

Among several protease inhibitors tested, only leupeptin was found to modify qualitatively the processing of P126, a major antigen of the parasitophorous vacuole of Plasmodium falciparum, and to inhibit the release of merozoites. Whereas P126 is normally processed upon merozoite release into 2 polypeptides of 50 and 73 kDa which are discharged in the culture medium, leupeptin treatment led to the recovery of a 56 kDa fragment which was recognized by a monoclonal antibody specific for the 50 kDa polypeptide and of a 73 kDa fragment comigrating with the one obtained in normal culture conditions. Mild trypsinization of the 56 kDa polypeptide gave rise to a 50 kDa product the tryptic fragments of which comigrated with those of the 50 kDa antigen obtained from untreated cultures.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2657420     DOI: 10.1016/0166-6851(89)90029-7

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  12 in total

1.  Altered plasmodial surface anion channel activity and in vitro resistance to permeating antimalarial compounds.

Authors:  Godfrey Lisk; Margaret Pain; Morgan Sellers; Philip A Gurnev; Ajay D Pillai; Sergey M Bezrukov; Sanjay A Desai
Journal:  Biochim Biophys Acta       Date:  2010-05-06

2.  Centenary celebrations article: Cysteine proteases of human malaria parasites.

Authors:  Kailash C Pandey
Journal:  J Parasit Dis       Date:  2011-12-03

3.  H-2b restriction of the immune response to the p126 Plasmodium falciparum antigen.

Authors:  D M Banic; P Delplace; C Mazingue; D Camus
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

4.  Immune responses induced by gene gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum.

Authors:  A A Belperron; D Feltquate; B A Fox; T Horii; D J Bzik
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: adjuvant effects on induction of protective immunity.

Authors:  J Inselburg; I C Bathurst; J Kansopon; G L Barchfeld; P J Barr; R N Rossan
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  Inhibition of malaria parasite development by a cyclic peptide that targets the vital parasite protein SERA5.

Authors:  W Douglas Fairlie; Tim P Spurck; Joanne E McCoubrie; Paul R Gilson; Susanne K Miller; Geoffrey I McFadden; Robyn Malby; Brendan S Crabb; Anthony N Hodder
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

7.  Malaria parasite exit from the host erythrocyte: a two-step process requiring extraerythrocytic proteolysis.

Authors:  B L Salmon; A Oksman; D E Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

8.  Falstatin, a cysteine protease inhibitor of Plasmodium falciparum, facilitates erythrocyte invasion.

Authors:  Kailash C Pandey; Naresh Singh; Shirin Arastu-Kapur; Matthew Bogyo; Philip J Rosenthal
Journal:  PLoS Pathog       Date:  2006-11       Impact factor: 6.823

9.  Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon.

Authors:  Lilian Rose Pratt-Riccio; Selma Sallenave-Sales; Joseli de Oliveira-Ferreira; Bruno T da Silva; Monick Lindenmeyer Guimarães; Fátima Santos; Thatiane S de Simone; Mariza G Morgado; Salvatore G de Simone; Maria de Fátima Ferreira-Da-Cruz; Cláudio T Daniel-Ribeiro; Mariano G Zalis; Daniel Camus; Dalma M Banic
Journal:  Malar J       Date:  2008-07-30       Impact factor: 2.979

10.  Expression and processing of Plasmodium berghei SERA3 during liver stages.

Authors:  Anja Schmidt-Christensen; Angelika Sturm; Sebastian Horstmann; Volker T Heussler
Journal:  Cell Microbiol       Date:  2008-04-17       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.